Therefore, significant reduction in percentage of CD11b, IL‐6, TUNEL, or APG5L/ATG cells, which are in particular seen after 20 weeks of CED, seem to be responsible for the inhibition of atherosclerosis progression after 20 weeks of CED. The gene discussed is ITGAM; the disease is cranioectodermal dysplasia.